Nisa Leung - Profile and Investment Details

Investor Profile

Nisa Leung is a Venture Capital, Private Equity Firm, Investment Partner, Investor based in United States with a diverse investment portfolio that includes companies such as Saints Sages Medical, Berry Genomics, Novast Pharmaceuticals Ltd., DiNovA Medtech, Broncus Technologies, Yunji Technology, Venus MedTech, Shenogen Pharma Group, Cool College, NVX Clouds Tech, Chaodian Culture, MediLink-Global, Mitralign, Woof, Insight Lifetech, Abbisko TherapeuticsMicrotech Medical, Zion Pharma, 52toys, Fucunbao, WeRide.ai, Kira Pharmaceuticals, Inbilin, Medilink Therapeutics, Belief Biomed, Basecamp Bio, Antengene Corporation, Alamar Biosciences, Sino Biological, Wuxi Vision Pro, Singular Medical, Gaugene, Xueba100.com, EpiBiologics, Amoy Diagnostic Co., Ltd., Delta Medical, ACEA BIO, Liangyihui, Sunny Dental, Health Biotech, CureGenetics, InfStones, Genius, ShouTi, 61Draw.com, Casela, Biren Technology, dMed, Bioscience, Chuhang Tech, SinoTau, Bioyond Tech, VR Medical Inc., Wuli Planet, GYENNO Technologies, Crown Bioscience, IntoCare, New Horizon Health, LIH Investment & Management, CanSinoBIO, Shulan Health, Beijing Richen-Force Science & Technology, Newsoara, Morewis, Pratilipi, Vongi, TUNGEE, Brise Pharma, Berry Oncology, ZSHK Laboratories, Nuohui Health, NEIWAI, InventisBio, Liuyi Jiaoyu, Plum, Leyden Labs, Weiqiang Medical Technology, Valgen Medtech, Zhenge Biotech, XSKY Data Technology, Sanegene Bio, Axera, Hope Medicine, Genevide, OriginCell, OriGene Technologies, Inc, Wholee, Miaoshou Doctor, Yunyinggu, Vistel, Tisenc, Compart Systems, Dishangtie, Clinflash Heathcare Technology, Asieris Pharmaceuticals, Erwan Technology, Schrödinger, CMLabs, Chushou, Cornerstone Robotics, Zhejiang JFK, Nice Tuan, PlusLife Biotech, Cadent Therapeutics, Zeen Health, Zai Lab, Hangzhou Weier, Emulate, Inc., Core Medical, BrainHealth, Kingsware, ZEGO Technology, SinoUnited Health Clinic, XellSmart, Yuanxin Huibao, Shukun Technology, VR Medical, Fingo, DP Technology, YUANBAO TECH, Beijing Aeonmed Ltd., RFoneTech, Insilico Medicine, Jacobio Pharmaceuticals, Hong Kong Science and Technology Parks Corporation, Crown Bioscience, Inc., Qiagen Suzhou Translational Medicine, KeChow Pharma, Sinocelltech, Nurotron Biotechnology, imToken, Connect Biopharmaceuticals, Bouffalo Lab, . Over time, Nisa Leung has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nisa Leung is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Autonomous Vehicles, Computer Vision, Investment Management, Cryptocurrency, Education, Artificial Intelligence (AI), Information Services, Information Technology (IT), Software, Manufacturing, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Employee Benefits, Consumer Software, Hardware, Insurance, Health Diagnostics, Medical, SaaS, Real Estate, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Nisa Leung, as their portfolio suggests a familiarity and interest in this area.

Understanding Nisa Leung’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.